TRV GP IV, LLC — Q4 2025 13F-HR

← TRV GP IV, LLC

Q4 2025 · 13F-HR

TRV GP IV, LLCholdings as filed

Filed 2026-02-13 · accession 0001193125-26-051795

$255.1M

Reported value

Positions

2025-12-31

Period end

View analyzed profile →PRO

The Brief · TRV GP IV, LLC · Q4 2025

AI · grounded in 13F

TRV GP IV, LLC reduced its position in Tango Therapeutics, Inc. TNGX by 43.2%. The fund also trimmed its holding in Maze Therapeutics, Inc. MAZE by 26.3%. These were the only changes to a portfolio consisting of two positions with total assets under management of $255.1M.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
578784100	MAZE	MAZE THERAPEUTICS, INC.	$185.4M	72.7%	4,473,958	Common	SOLE
87583X109	TNGX	TANGO THERAPEUTICS, INC.	$69.8M	27.3%	7,874,574	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.